Androgenic Alopecia. Androgenic alopecia
Conditions
Interventions
Intervention 1: Intervention group: In the first group, one third of the patients, which are estimated to be 15, are treated with 2.5 mg oral minoxidil tablets, 1 tablet per day for a period of 6 mont
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients aged 18 to 60 years with male androgenetic alopecia grade 2 to 4 vertex of Norwood-Hamilton classification who have not received any other medical treatment for hair loss in the last 6 months
Exclusion criteria
Exclusion criteria: Patients who are not diagnosed with androgenic alopecia or are being treated with other drugs, and patients with grade I of androgenic alopecia and patients with severe complications after taking drugs are excluded from the study. Liver and TSH tests (tests in the last 6 months can be it is accepted) it is requested that they will be excluded from the study in case of disorder. Patients with a history of hair transplantation and patients with prostate and breast cancer in the last 5 years will be excluded from the study. patients with a history of diseases related to the right ventricle and neurogenic hypotension And spinal injuries are not included in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Counting the number and density of hair with Trichoscan. Timepoint: Before the start of the study and 2,4,6 months after the start of the intervention. Method of measurement: Trichoscan. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of hair changes and hair growth with photography. Timepoint: Before the start of the study and 2,4,6 months after the start of the intervention. Method of measurement: Photographic Examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Firooz
Tehran University of Medical Sciences
Outcome results
None listed